Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influenza virus vaccine trivalent - Novavax

Next Previous
Drug Profile

Influenza virus vaccine trivalent - Novavax

Alternative Names: CadiFlu-S; Influenza virus-like particle vaccine trivalent - Novavax; Novavax trivalent vaccine; Seasonal influenza VLP vaccine - Novavax; VLP-based trivalent seasonal influenza vaccine - Novavax

Latest Information Update: 23 Nov 2016

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novavax
  • Developer CPL Biologicals; Novavax
  • Class Influenza virus vaccines; Virus-like particle vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza virus infections

Most Recent Events

  • 17 Nov 2016 Launched for Influenza virus infections (Prevention) in India (IM)
  • 06 Aug 2015 Phase-II development is ongoing in USA and Australia
  • 31 Dec 2014 Phase-III clinical trials in Influenza virus infections (Prevention) in India (IM)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top